Halia Therapeutics Announces $30M Series C Financing to Advance Novel Pipeline of Anti-Inflammatory Therapeutics

Posted on

Funds will support the advancement of lead programs in Phase II clinical trials, evaluating HT-6184, Halia’s first-in-class NLRP3/NEK7 inflammasome inhibitor, and advancing additional programs into the clinic. LEHI, Utah, Jan. 31, 2024 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, today announced the completion […]

Read More

Bloom Surgical Awarded Competitive Grant from the NSF

Funding accelerates development of device for resolving visual disruptions in robotic procedures Salt Lake City, UT, June 1, 2023 – Bloom Surgical, Inc., a Utah-based surgical device startup, has been awarded a U.S. National Science Foundation Small Business Innovation Research grant for $256,000 to conduct research and development work on a novel micro-mechanical wiping mechanism […]

Read More

Rep. Moore Calls For Increased Transparency in the NCD Process

Utah U.S. Rep. Blake Moore (R-UT) signed onto a letter to HHS/CMS, led by House Ways and Means Committee Chair Jason Smith (R-MO) and House Energy and Commerce Committee Chair Kathy McMorris-Rodgers (R-WA), calling for increaed transparency in the NCD process following the agency’s recent release of the TCET notice. In part, the letter states, […]

Read More

Denali Therapeutics, Alucent Biomedical, Present to Utah Life Sciences Innovation Caucus

Utah legislators on Wednesday, June 14, held a meeting of the Utah Life Sciences Innovation Caucus (ULSIC) at the state capitol. BioUtah President and CEO, Kelvyn Cullimore, kicked off the meeting and introduced representatives from Denali Therapeutics and Alucent Biomedical who presented before the ULSIC. Cindy Dunkle, chief people officer for Denali, described the company’s […]

Read More

House Health Panel Advances Legislation on PBM’s, Generic Drugs

The Energy and Commerce Health Subcommittee on Wednesday voted to advance a series of healthcare bills, largely on a bipartisan basis. The bills included reforms to the practices of pharmacy benefit managers (PBMs), improving access to generic drugs, and increasing transparency into the prices that hospitals, laboratories, and insurance companies charge. Of particular interest to the life […]

Read More

Representative Blake Moore Stands Up for Innovation

The House Ways and Means Subcommittee on Health on May 10 held a hearing examining government policies that inhibit medical innovation and patient access. Utah Representative Blake Moore (R-UT), a member of the subcommittee, raised concerns about the lack of an expedited Medicare coverage pathway for breakthrough medical technologies. He specifically called out how repeal […]

Read More

Recap of 2023 E&I Summit

The 2023 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit (E&I Summit), presented by BioUtah and the University of Utah PIVOT Center (PIVOT Center), held March 16 at the Eccles Alumni House at the University of Utah, continued its tradition of bringing together Utah’s life sciences leaders, entrepreneurs and the investor community. This year’s event […]

Read More